🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

BRIEF-Knight Receives Notice Of Reassessment For FY Ended Dec 31, 2014

Published 2018-07-06, 08:45 a/m
© Reuters.  BRIEF-Knight Receives Notice Of Reassessment For FY Ended Dec 31, 2014
GUD
-

July 6 (Reuters) - Knight Therapeutics Inc GUD.TO :

* KNIGHT RECEIVES ADVERSE NOTICE OF REASSESSMENT FROM CRA

* KNIGHT THERAPEUTICS INC - RECEIVED A NOTICE OF REASSESSMENT FROM CANADA REVENUE AGENCY FOR ITS FISCAL YEAR ENDED DECEMBER 31, 2014

* KNIGHT THERAPEUTICS - CRA NOTICE RELATES TO DISPOSITION OF PRIORITY REVIEW VOUCHER GRANTED ON MARCH 19, 2014, UPON U.S. FDA'S APPROVAL OF IMPAVIDO

* KNIGHT THERAPEUTICS INC - CRA NOTICE PROVIDES THAT KNIGHT IS LIABLE TO PAY TO CRA AN AGGREGATE OF $23.3 MILLION IN ADDITIONAL TAXES AND INTEREST

* KNIGHT THERAPEUTICS INC - INTENDS TO CONTEST CRA NOTICE BY FILING A NOTICE OF OBJECTION TO START APPEALS PROCESS

* KNIGHT THERAPEUTICS INC - IN CONNECTION WITH APPEALS PROCESS, HAS MADE A DEPOSIT OF $23.3 MILLION TO CRA, WILL MAKE ESTIMATED DEPOSIT OF $19.0 MILLION TO QRA

* KNIGHT THERAPEUTICS INC - HAS NOT RECORDED ANY TAX PROVISION FOR TOTAL TAX LIABILITY IN ITS FINANCIAL STATEMENTS

* KNIGHT THERAPEUTICS - LIKELY THAT QUEBEC REVENUE AGENCY WILL PROPOSE SIMILAR ADJUSTMENT WHICH WILL RESULT IN ADDITIONAL TAX LIABILITY OF $19.0 MILLION

* KNIGHT THERAPEUTICS - FINAL DETERMINATION OF TAX AUDITS, RELATED DISPUTES COULD BE DIFFERENT FROM HISTORICAL INCOME TAX PROVISIONS, ACCRUALS

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.